PLIANT THERAPEUTICS INC (PLRX)

US7291391057 - Common Stock

13.25  +0.59 (+4.66%)

After market: 13.25 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.58M9.69M7.57M41.82M57.05M
Operating Expenses
185.72M136.89M105.11M83.46M58.28M
Research and Development
127.80M96.94M77.55M66.19M47.35M
Selling, General, and Administrative Expenses
57.93M39.95M27.56M17.27M10.93M
Operating Income
-184.15M-127.20M-97.54M-41.65M-1.23M
Interest Income/Expense
22.81M3.88M270.00K480.00K820.00K
Other Income/Expense
N/AN/AN/A-370.00K-220.00K
Income Before Taxes
-161.34M-123.32M-97.26M-41.53M-630.00K
Net Income
-161.34M-123.32M-97.26M-41.53M-6.86M
EBITDA
-182.30M-125.38M-96.00M-40.34M-120.00K
 
Per Share Data
EPS Diluted Total Ops
-2.75-2.94-2.71-1.95-0.20
Non GAAP EPS
-2.76-2.97-2.71N/AN/A
 
Statistics
Profit Margin
-10211.14%-1272.65%-1284.81%-99.31%-12.02%
Operating Profit Margin
-11654.75%-1312.69%-1288.51%-99.59%-2.16%

All data in USD

Charts